Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changbin Shi

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Human Molecular Genetics|April 5, 2014
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesisDavid A McDonald, Changbin Shi, Robert Shenkar, et al.
Iscience|December 5, 2022
Role of pericytes in the development of cerebral cavernous malformationsZifeng Dai, Jingwei Li, Ying Li, et al.
Stroke|December 5, 2013
Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformationsAbdul Ghani Mikati, Huan Tan, Robert Shenkar, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 14, 2015
Vascular permeability in cerebral cavernous malformationsAbdul G Mikati, Omaditya Khanna, Lingjiao Zhang, et al.
Journal of Autoimmunity|May 5, 2020
Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieuDongdong Zhang, Andrew J Kinloch, Abhinav Srinath, et al.
Journal of Autoimmunity|September 25, 2023
Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469]Dongdong Zhang, Andrew J Kinloch, Abhinav Srinath, et al.
Journal of Neurosurgery|August 6, 2016
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformationsRomuald Girard, Maged D Fam, Hussein A Zeineddine, et al.
Biomarkers in Medicine|February 11, 2016
Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation diseaseRomuald Girard, Omaditya Khanna, Robert Shenkar, et al.
Neuro-Oncology|January 28, 2014
MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivoGuang Yang, Dayong Han, Xin Chen, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 18, 2016
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine ModelsChangbin Shi, Robert Shenkar, Hussein A Zeineddine, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Human Molecular Genetics|April 5, 2014
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesisDavid A McDonald, Changbin Shi, Robert Shenkar, et al.
Iscience|December 5, 2022
Role of pericytes in the development of cerebral cavernous malformationsZifeng Dai, Jingwei Li, Ying Li, et al.
Stroke|December 5, 2013
Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformationsAbdul Ghani Mikati, Huan Tan, Robert Shenkar, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 14, 2015
Vascular permeability in cerebral cavernous malformationsAbdul G Mikati, Omaditya Khanna, Lingjiao Zhang, et al.
Journal of Autoimmunity|May 5, 2020
Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieuDongdong Zhang, Andrew J Kinloch, Abhinav Srinath, et al.
Journal of Autoimmunity|September 25, 2023
Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469]Dongdong Zhang, Andrew J Kinloch, Abhinav Srinath, et al.
Journal of Neurosurgery|August 6, 2016
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformationsRomuald Girard, Maged D Fam, Hussein A Zeineddine, et al.
Biomarkers in Medicine|February 11, 2016
Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation diseaseRomuald Girard, Omaditya Khanna, Robert Shenkar, et al.
Neuro-Oncology|January 28, 2014
MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivoGuang Yang, Dayong Han, Xin Chen, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 18, 2016
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine ModelsChangbin Shi, Robert Shenkar, Hussein A Zeineddine, et al.
Pageof 6